MHRA Safety Roundup: May 2025

View as a webpage / Share

MHRA Safety Roundup

May 2025

MHRA Safety Roundup: May 2025

This month's MHRA Safety Roundup includes:

Drug Safety Update on Thiopurines and intrahepatic cholestasis of pregnancy
Drug Safety Update on Kaftrio▼(Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects
Letters, medicines recalls and device notifications sent to healthcare professionals in May 2025
News on updates to HRT product information, biotin interference with thyroid function tests and the launch of a new MHRA consultation

May's Safety Roundup is now available to read as a downloadable document or on the GOV.UK website

It's easy to report

Report a suspected adverse drug reaction online
or download the Yellow Card app

REPORT ONLINE

Thank you,

The Medicines and Healthcare products Regulatory Agency

If you would like to share this with a friend or colleague, hit the Forward button or send them this link to view the email in a browser.

Unsubscribe or change your email address at any time on your subscriber preferences page.

If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.

All other enquiries can be directed to email.support@mhra.gov.uk.

This is an automatically generated email. Please do not reply directly to this notification.
This service is provided to you at no charge by the Medicines and Healthcare products Regulatory Agency.